Toshihiro Akihisa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Toshihiro Akihisa has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
Makoto Fukatsu
6 shared publications- Takashi Kikuchi
Faculty of Pharmaceutical Sciences, Toho University, Miyama 2-2-1, Funabashi 274-8510, Chiba, Japan
6 shared publications Harukuni Tokuda
5 shared publicationsYumiko Kimura
School of Pharmacy, Nihon University, 7-7-1 Narashinodai, Funabashi-shi, Chiba 274-8555, Japan
4 shared publicationsAyako Yamamoto
College of Science and Technology, Nihon University, 1-8-14 Kanda Surugadai, Chiyoda-ku, Tokyo 101-8308, Japan (phone: +81-3-3259 0806; fax: +81-3-3293 7572)
3 shared publicationsEri Ogihara
3 shared publications
Latest Publications
- 1 May 2013
- Published by Elsevier in Phytochemistry
- Vol. 89, 59-70
Limonoids from the fruits of Melia azedarach and their cytotoxic activities
- 1 May 2013
- Published by Elsevier in Phytochemistry
- Vol. 89, 59-70
Limonoids from the fruits of Melia azedarach and their cytotoxic activities
- 18 February 2013
- Published by Wiley in Chemistry & Biodiversity
- Vol. 10 (2) , 167-176
Melanogenesis‐Inhibitory Activity of Aromatic Glycosides from the Stem Bark of Acer buergerianum
A new benzyl glucoside, 3-O-demethylnikoenoside (1), along with eleven known compounds, including seven aromatic glycosides, 2–8, three lignans, 9–11, and one cyclitol, 12, were isolated from the BuOH-soluble fraction of a MeOH extract of Acer buergerianum stem bark. The structures of the new compound were elucidated on the basis of extensive spectroscopic analyses and comparison with literature. Upon evaluation of compounds 1–12 on melanogenesis in B16 melanoma cells induced with α-melanocyte-stimulating hormone (α-MSH), three compounds, i.e., hovetrichoside B (8), pinoresinol 4-O-β-D-glucopyranoside (9), and pinoresinol 4-O-β-D-apiofuranosyl-(1→2)-β-D-glucopyranoside (10), have been found to exhibit inhibitory effects with 41–49% melanin content compared to the control at 100 μM and low cytotoxicity to the cells (81–92% cell viability at 100 μM). Western blot analysis showed that compound 8 reduced the protein levels of MITF (=microphtalmia-associated transcription factor) and tyrosinase, in a concentration-dependent manner, suggesting that 8 inhibits melanogenesis in α-MSH-stimulated B16 melanoma cells by, at least in part, inhibiting the expression of MITF, followed by decreasing the expression of tyrosinase. On the other hand, upon Western blotting, compound 9 was found to reduce the protein levels of tyrosinase and TRP-2, while it increased MITF and TRP-1 (=tyrosine-related protein 1), in a concentration-dependent manner, indicating that 9 inhibits melanogenesis in α-MSH-stimulated B16 melanoma cells by, at least in part, inhibiting the expression of tyrosinase and TRP-2.
- 18 February 2013
- Published by Wiley in Chemistry & Biodiversity
- Vol. 10 (2) , 167-176
Melanogenesis‐Inhibitory Activity of Aromatic Glycosides from the Stem Bark of Acer buergerianum
A new benzyl glucoside, 3-O-demethylnikoenoside (1), along with eleven known compounds, including seven aromatic glycosides, 2–8, three lignans, 9–11, and one cyclitol, 12, were isolated from the BuOH-soluble fraction of a MeOH extract of Acer buergerianum stem bark. The structures of the new compound were elucidated on the basis of extensive spectroscopic analyses and comparison with literature. Upon evaluation of compounds 1–12 on melanogenesis in B16 melanoma cells induced with α-melanocyte-stimulating hormone (α-MSH), three compounds, i.e., hovetrichoside B (8), pinoresinol 4-O-β-D-glucopyranoside (9), and pinoresinol 4-O-β-D-apiofuranosyl-(1→2)-β-D-glucopyranoside (10), have been found to exhibit inhibitory effects with 41–49% melanin content compared to the control at 100 μM and low cytotoxicity to the cells (81–92% cell viability at 100 μM). Western blot analysis showed that compound 8 reduced the protein levels of MITF (=microphtalmia-associated transcription factor) and tyrosinase, in a concentration-dependent manner, suggesting that 8 inhibits melanogenesis in α-MSH-stimulated B16 melanoma cells by, at least in part, inhibiting the expression of MITF, followed by decreasing the expression of tyrosinase. On the other hand, upon Western blotting, compound 9 was found to reduce the protein levels of tyrosinase and TRP-2, while it increased MITF and TRP-1 (=tyrosine-related protein 1), in a concentration-dependent manner, indicating that 9 inhibits melanogenesis in α-MSH-stimulated B16 melanoma cells by, at least in part, inhibiting the expression of tyrosinase and TRP-2.
- 1 January 2013
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 36 (1) , 135-139
Cytotoxic and Apoptosis-Inducing Activities of 12-O-Acetylazedarachin B from the Fruits of Melia azedarach in Human Cancer Cell Lines
12-O-Acetylazedarachin B (1), isolated from the fruit extract of Melia azedarach, exhibited potent cytotoxicity against leukemia (HL-60) (IC50 0.016 µM) and stomach (AZ521) (IC50 0.035 µM) cancer cell lines. Upon assessing the apoptosis-inducing activity in HL-60 cells, compound 1 exhibited induction of apoptosis detected by the observation of membrane phospholipid exposure and DNA fragmentation in flow cytometry. Western blot analysis showed that 1 markedly reduced the levels of procaspases-3, 8, and 9, while being increased the levels of cleaved caspases-3, 8, and 9. In addition, compound 1 increased significantly Bax/Bcl-2 ratio. These results suggested that 1 induced apoptotic cell death in HL-60 via both mitochondrial and death receptor-mediated pathways. Therefore, compound 1 may be promising lead compound for developing an effective drug for treatment of leukemia. Flow cytometric analysis suggested that the cytotoxicity of 1 against AZ521 is due to inducing apoptosis as well as necrosis with the latter predominated.
- 1 January 2013
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 36 (1) , 135-139
Cytotoxic and Apoptosis-Inducing Activities of 12-O-Acetylazedarachin B from the Fruits of Melia azedarach in Human Cancer Cell Lines
12-O-Acetylazedarachin B (1), isolated from the fruit extract of Melia azedarach, exhibited potent cytotoxicity against leukemia (HL-60) (IC50 0.016 µM) and stomach (AZ521) (IC50 0.035 µM) cancer cell lines. Upon assessing the apoptosis-inducing activity in HL-60 cells, compound 1 exhibited induction of apoptosis detected by the observation of membrane phospholipid exposure and DNA fragmentation in flow cytometry. Western blot analysis showed that 1 markedly reduced the levels of procaspases-3, 8, and 9, while being increased the levels of cleaved caspases-3, 8, and 9. In addition, compound 1 increased significantly Bax/Bcl-2 ratio. These results suggested that 1 induced apoptotic cell death in HL-60 via both mitochondrial and death receptor-mediated pathways. Therefore, compound 1 may be promising lead compound for developing an effective drug for treatment of leukemia. Flow cytometric analysis suggested that the cytotoxicity of 1 against AZ521 is due to inducing apoptosis as well as necrosis with the latter predominated.
- 17 August 2012
- Published by Wiley in Chemistry & Biodiversity
- Vol. 9 (8) , 1475-1489
Melanogenesis‐Inhibitory and Cytotoxic Activities of Diarylheptanoids from Acer nikoense Bark and Their Derivatives
Nine cyclic diarylheptanoids, 1–9, including two new compounds, i.e., 9‐oxoacerogenin A (8) and 9‐O‐β‐D‐glucopyranosylacerogenin K (9), along with three acyclic diarylheptanoids, 10–12, and four phenolic compounds, 13–16, were isolated from a MeOH extract of the bark of Acer nikoense (Aceraceae). Acid hydrolysis of 9 yielded acerogenin K (17) and D‐glucose. Two of the cyclic diarylheptanoids, acerogenin A (1) and (R)‐acerogenin B (5), were converted to their ether and ester derivatives, 18–24 and 27–33, respectively, and to the dehydrated derivatives, 25, 26, 34, and 35. Upon evaluation of compounds 1–16 and 18–35 for their inhibitory activities against melanogenesis in B16 melanoma cells, induced with α‐melanocyte‐stimulating hormone (α‐MSH), eight natural glycosides, i.e., six diarylheptanoid glycosides, 2–4, 6, 9, and 12, and two phenolic glycosides, 15 and 16, exhibited inhibitory activities with 24–61% reduction of melanin content at 100 μM concentration with no or almost no toxicity to the cells (88–106% of cell viability at 100 μM). In addition, when compounds 1–16 and 18–35 were evaluated for cytotoxic activity against human cancer cell lines, two natural acyclic diarylheptanoids, 10 and 11, ten ether and ester derivatives, 18–22 and 27–31, and two dehydrated derivatives, 34 and 35, exhibited potent cytotoxicities against HL60 human leukemia cell line (IC50 8.1–19.3 μM), and five compounds, 10, 11, 20, 29, and 30, against CRL1579 human melanoma cell line (IC50 10.1–18.4 μM).
- 17 August 2012
- Published by Wiley in Chemistry & Biodiversity
- Vol. 9 (8) , 1475-1489
Melanogenesis‐Inhibitory and Cytotoxic Activities of Diarylheptanoids from Acer nikoense Bark and Their Derivatives
Nine cyclic diarylheptanoids, 1–9, including two new compounds, i.e., 9‐oxoacerogenin A (8) and 9‐O‐β‐D‐glucopyranosylacerogenin K (9), along with three acyclic diarylheptanoids, 10–12, and four phenolic compounds, 13–16, were isolated from a MeOH extract of the bark of Acer nikoense (Aceraceae). Acid hydrolysis of 9 yielded acerogenin K (17) and D‐glucose. Two of the cyclic diarylheptanoids, acerogenin A (1) and (R)‐acerogenin B (5), were converted to their ether and ester derivatives, 18–24 and 27–33, respectively, and to the dehydrated derivatives, 25, 26, 34, and 35. Upon evaluation of compounds 1–16 and 18–35 for their inhibitory activities against melanogenesis in B16 melanoma cells, induced with α‐melanocyte‐stimulating hormone (α‐MSH), eight natural glycosides, i.e., six diarylheptanoid glycosides, 2–4, 6, 9, and 12, and two phenolic glycosides, 15 and 16, exhibited inhibitory activities with 24–61% reduction of melanin content at 100 μM concentration with no or almost no toxicity to the cells (88–106% of cell viability at 100 μM). In addition, when compounds 1–16 and 18–35 were evaluated for cytotoxic activity against human cancer cell lines, two natural acyclic diarylheptanoids, 10 and 11, ten ether and ester derivatives, 18–22 and 27–31, and two dehydrated derivatives, 34 and 35, exhibited potent cytotoxicities against HL60 human leukemia cell line (IC50 8.1–19.3 μM), and five compounds, 10, 11, 20, 29, and 30, against CRL1579 human melanoma cell line (IC50 10.1–18.4 μM).
- 17 August 2012
- Published by Wiley in Chemistry & Biodiversity
- Vol. 9 (8) , 1490-1499
Melanogenesis Inhibitory Activity of Monoterpene Glycosides from Gardeniae Fructus
A new iridoid glycoside, 10‐O‐(4″‐O‐methylsuccinoyl)geniposide (7), and two new pyronane glycosides, jasminosides Q and R (13 and 14, resp.), along with nine known iridoid glycosides, 1–6 and 8–10, and two known pyronane glycosides, 11 and 12, were isolated from a MeOH extract of Gardeniae Fructus, the dried ripe fruit of Gardenia jasminoides (Rubiaceae). The structures of new compounds were elucidated on the basis of extensive spectroscopic analyses and comparison with literature. Upon evaluation of compounds 1–14 on the melanogenesis in B16 melanoma cells induced with α‐melanocyte‐stimulating hormone (α‐MSH), three compounds, i.e., 6‐O‐p‐coumaroylgeniposide (3), 7, and 6′‐O‐sinapoyljasminoside (12), exhibited inhibitory effects with 21.6–41.0 and 37.5–47.7% reduction of melanin content at 30 and 50 μM, respectively, with almost no toxicity to the cells (83.7–106.1% of cell viability at 50 μM).
- 17 August 2012
- Published by Wiley in Chemistry & Biodiversity
- Vol. 9 (8) , 1490-1499
Melanogenesis Inhibitory Activity of Monoterpene Glycosides from Gardeniae Fructus
A new iridoid glycoside, 10‐O‐(4″‐O‐methylsuccinoyl)geniposide (7), and two new pyronane glycosides, jasminosides Q and R (13 and 14, resp.), along with nine known iridoid glycosides, 1–6 and 8–10, and two known pyronane glycosides, 11 and 12, were isolated from a MeOH extract of Gardeniae Fructus, the dried ripe fruit of Gardenia jasminoides (Rubiaceae). The structures of new compounds were elucidated on the basis of extensive spectroscopic analyses and comparison with literature. Upon evaluation of compounds 1–14 on the melanogenesis in B16 melanoma cells induced with α‐melanocyte‐stimulating hormone (α‐MSH), three compounds, i.e., 6‐O‐p‐coumaroylgeniposide (3), 7, and 6′‐O‐sinapoyljasminoside (12), exhibited inhibitory effects with 21.6–41.0 and 37.5–47.7% reduction of melanin content at 30 and 50 μM, respectively, with almost no toxicity to the cells (83.7–106.1% of cell viability at 50 μM).
- 15 June 2012
- Published by Wiley in Chemistry & Biodiversity
- Vol. 9 (6) , 1172-1187
Melanogenesis‐Inhibitory Saccharide Fatty Acid Esters and Other Constituents of the Fruits of Morinda citrifolia (Noni)
Five new saccharide fatty acid esters, named nonioside P (3), nonioside Q (4), nonioside R (8), nonioside S (10), and nonioside T (14), and one new succinic acid ester, butyl 2‐hydroxysuccinate (=4‐butoxy‐3‐hydroxy‐4‐oxobutanoic acid) (31), were isolated, along with 26 known compounds, including eight saccharide fatty acid esters, 1, 2, 5, 6, 7, 9, 12, and 13, three hemiterpene glycosides, 15, 17, and 18, six iridoid glycosides, 21–25, and 27, and nine other compounds, 20, 28, 29, and 32–37, from a MeOH extract of the fruit of Morinda citrifolia (noni). Upon evaluation of these and five other glycosidic compounds, 11, 16, 19, 26, and 30, from M. citrifolia fruit extract for their inhibitory activities against melanogenesis in B16 melanoma cells induced with α‐melanocyte‐stimulating hormone (α‐MSH), most of the saccharide fatty acid esters, hemiterpene glycosides, and iridoid glycosides showed inhibitory effects with no or almost no toxicity to the cells. These compounds were further evaluated with respect to their cytotoxic activities against two human cancer cell lines (HL‐60 and AZ521) and their inhibitory effects on EpsteinBarr virus early antigen (EBV‐EA) activation induced with 12‐O‐tetradecanoylphorbol‐13‐acetate (TPA) in Raji cells.
- 15 June 2012
- Published by Wiley in Chemistry & Biodiversity
- Vol. 9 (6) , 1172-1187
Melanogenesis‐Inhibitory Saccharide Fatty Acid Esters and Other Constituents of the Fruits of Morinda citrifolia (Noni)
Five new saccharide fatty acid esters, named nonioside P (3), nonioside Q (4), nonioside R (8), nonioside S (10), and nonioside T (14), and one new succinic acid ester, butyl 2‐hydroxysuccinate (=4‐butoxy‐3‐hydroxy‐4‐oxobutanoic acid) (31), were isolated, along with 26 known compounds, including eight saccharide fatty acid esters, 1, 2, 5, 6, 7, 9, 12, and 13, three hemiterpene glycosides, 15, 17, and 18, six iridoid glycosides, 21–25, and 27, and nine other compounds, 20, 28, 29, and 32–37, from a MeOH extract of the fruit of Morinda citrifolia (noni). Upon evaluation of these and five other glycosidic compounds, 11, 16, 19, 26, and 30, from M. citrifolia fruit extract for their inhibitory activities against melanogenesis in B16 melanoma cells induced with α‐melanocyte‐stimulating hormone (α‐MSH), most of the saccharide fatty acid esters, hemiterpene glycosides, and iridoid glycosides showed inhibitory effects with no or almost no toxicity to the cells. These compounds were further evaluated with respect to their cytotoxic activities against two human cancer cell lines (HL‐60 and AZ521) and their inhibitory effects on EpsteinBarr virus early antigen (EBV‐EA) activation induced with 12‐O‐tetradecanoylphorbol‐13‐acetate (TPA) in Raji cells.
- 15 June 2012
- Published by Wiley in Chemistry & Biodiversity
- Vol. 9 (6) , 1045-1054
Anti‐Inflammatory and Anti‐Tumor‐Promoting Effects of 5‐Deprenyllupulonol C and Other Compounds from Hop (Humulus lupulus L.)
A new phloroglucinol derivative, 5‐deprenyllupulonol C (1), along with four other phloroglucinol derivatives, 2–5, five chalcones, 6–10, four flavanones, 11–14, two flavonol glycosides, 15 and 16, and five triterpenoids, 17–21, were isolated from the female inflorescence pellet extracts of hop (Humulus lupulus L.). Upon evaluation of these compounds against the EpsteinBarr virus early antigen (EBV‐EA) activation induced by 12‐O‐tetradecanoylphorbol 13‐acetate (TPA) in Raji cells, twelve compounds, i.e., 1–4, 11–14, 17–19, and 21, showed potent inhibitory effects on EBV‐EA induction, with IC50 values in the range of 215–393 mol ratio/32 pmol TPA. In addition, eleven compounds, i.e., 1–4, 6, 11, 12, 14, 17, 18, and 20, were found to inhibit TPA‐induced inflammation (1 μg/ear) in mice, with ID50 values in the range of 0.13–1.06 μmol per ear. Further, lupulone C (2) and 6‐prenylnaringenin (14) exhibited inhibitory effects on skin‐tumor promotion in an in vivo two‐stage mouse‐skin carcinogenesis test based on 7,12‐dimethylbenz[a]anthracene (DMBA) as initiator and with TPA as promoter.
- 15 June 2012
- Published by Wiley in Chemistry & Biodiversity
- Vol. 9 (6) , 1045-1054
Anti‐Inflammatory and Anti‐Tumor‐Promoting Effects of 5‐Deprenyllupulonol C and Other Compounds from Hop (Humulus lupulus L.)
A new phloroglucinol derivative, 5‐deprenyllupulonol C (1), along with four other phloroglucinol derivatives, 2–5, five chalcones, 6–10, four flavanones, 11–14, two flavonol glycosides, 15 and 16, and five triterpenoids, 17–21, were isolated from the female inflorescence pellet extracts of hop (Humulus lupulus L.). Upon evaluation of these compounds against the EpsteinBarr virus early antigen (EBV‐EA) activation induced by 12‐O‐tetradecanoylphorbol 13‐acetate (TPA) in Raji cells, twelve compounds, i.e., 1–4, 11–14, 17–19, and 21, showed potent inhibitory effects on EBV‐EA induction, with IC50 values in the range of 215–393 mol ratio/32 pmol TPA. In addition, eleven compounds, i.e., 1–4, 6, 11, 12, 14, 17, 18, and 20, were found to inhibit TPA‐induced inflammation (1 μg/ear) in mice, with ID50 values in the range of 0.13–1.06 μmol per ear. Further, lupulone C (2) and 6‐prenylnaringenin (14) exhibited inhibitory effects on skin‐tumor promotion in an in vivo two‐stage mouse‐skin carcinogenesis test based on 7,12‐dimethylbenz[a]anthracene (DMBA) as initiator and with TPA as promoter.
- 16 February 2012
- Published by Wiley in Chemistry & Biodiversity
- Vol. 9 (2) , 318-330
Cytotoxic Activities and Anti‐Tumor‐Promoting Effects of Microbial Transformation Products of Prenylated Chalcones from Angelica keiskei
Three prenylated chalcones, 4‐hydroxyderricin (1), xanthoangelol (2), and xanthoangelol F (3), isolated from Angelica keiskei, were transformed by the fungus Aspergillus saitoi. These chalcones were converted to flavanones (i.e., 4, 8, and 12), and prenyl‐chain‐hydrated (i.e., 5, 7, 9–11, and 13) and ring‐B‐hydroxylated (i.e., 6) chalcones. The structures of three new metabolites, 7, 9, and 13, were established as 2″,3″‐dihydro‐4,3″‐dihydroxyderricin, 6″,7″‐dihydro‐7″‐hydroxyxanthoangelol, and 6″,7″‐dihydro‐7″‐hydroxyxanthoangelol F, respectively. Upon evaluation of cytotoxic activities of compounds 1–13, the metabolite 7 exhibited potent cytotoxicity against HL60 cells, and this cell death was revealed to be mostly due to apoptosis. In addition, compounds 1–4, 7–10, 12, and 13 were examined for their inhibitory effects on the induction of EpsteinBarr virus early antigen (EBV‐EA) by 12‐O‐tetradecanoylphorbol‐13‐acetate (TPA) in Raji cells. All compounds tested showed inhibitory effects against EBV‐EA activation with potencies higher than that of β‐carotene. Furthermore, the metabolite 13 exhibited inhibitory effect on skin tumor promotion in an in vivo two‐stage mouse skin carcinogenesis test based on 7,12‐dimethylbenz[a]anthracene (DMBA) as initiator, and with TPA as promoter.
- 16 February 2012
- Published by Wiley in Chemistry & Biodiversity
- Vol. 9 (2) , 318-330
Cytotoxic Activities and Anti‐Tumor‐Promoting Effects of Microbial Transformation Products of Prenylated Chalcones from Angelica keiskei
Three prenylated chalcones, 4‐hydroxyderricin (1), xanthoangelol (2), and xanthoangelol F (3), isolated from Angelica keiskei, were transformed by the fungus Aspergillus saitoi. These chalcones were converted to flavanones (i.e., 4, 8, and 12), and prenyl‐chain‐hydrated (i.e., 5, 7, 9–11, and 13) and ring‐B‐hydroxylated (i.e., 6) chalcones. The structures of three new metabolites, 7, 9, and 13, were established as 2″,3″‐dihydro‐4,3″‐dihydroxyderricin, 6″,7″‐dihydro‐7″‐hydroxyxanthoangelol, and 6″,7″‐dihydro‐7″‐hydroxyxanthoangelol F, respectively. Upon evaluation of cytotoxic activities of compounds 1–13, the metabolite 7 exhibited potent cytotoxicity against HL60 cells, and this cell death was revealed to be mostly due to apoptosis. In addition, compounds 1–4, 7–10, 12, and 13 were examined for their inhibitory effects on the induction of EpsteinBarr virus early antigen (EBV‐EA) by 12‐O‐tetradecanoylphorbol‐13‐acetate (TPA) in Raji cells. All compounds tested showed inhibitory effects against EBV‐EA activation with potencies higher than that of β‐carotene. Furthermore, the metabolite 13 exhibited inhibitory effect on skin tumor promotion in an in vivo two‐stage mouse skin carcinogenesis test based on 7,12‐dimethylbenz[a]anthracene (DMBA) as initiator, and with TPA as promoter.
- 17 August 2010
- Published by Wiley in Chemistry & Biodiversity
- Vol. 7 (8) , 1871-1884
Antitumor‐Promoting Effects and Cytotoxic Activities of Dammar Resin Triterpenoids and Their Derivatives
Nineteen known triterpenoids, 1–19, and one known sesquiterpenoid, 20, were isolated from dammar resin obtained from Shorea javanica K. & V. (Dipterocarpaceae). One of the acidic triterpenoids, dammarenolic acid (1), was converted to fourteen derivatives, namely, an alcohol, 21, an aldehyde, 22, and twelve L‐amino acid conjugates, 23–34. Compounds 1–34 were examined for their inhibitory effects on the induction of Epstein–Barr virus early antigen (EBV‐EA) by 12‐O‐tetradecanoylphorbol 13‐acetate (TPA) in Raji cells, a known primary screening test for antitumor promoters. All of the compounds tested, except for compounds 4, 5, 12–14, 16, and 17, showed inhibitory effects against EBV‐EA activation with potencies either comparable with or stronger than that of β‐carotene, a known natural antitumor promoter. In addition, (20S)‐20‐hydroxy‐3,4‐secodammara‐4(28),24‐dien‐3‐al (22) exhibited inhibitory effects on skin tumor promotion in an in vivo two‐stage mouse skin carcinogenesis test based on 7,12‐dimethylbenz[a]anthracene (DMBA) as initiator, and with TPA as promoter. Furthermore, evaluation of the cytotoxic activities of compounds 1–34 against human cancer cell lines showed that reduction (i.e., 21 and 22) or conjugation with L‐amino acids (i.e., 23–34) of compound 1 enhanced the cytotoxicity against human melanoma cell line CRL1579.
- 17 August 2010
- Published by Wiley in Chemistry & Biodiversity
- Vol. 7 (8) , 1871-1884
Antitumor‐Promoting Effects and Cytotoxic Activities of Dammar Resin Triterpenoids and Their Derivatives
Nineteen known triterpenoids, 1–19, and one known sesquiterpenoid, 20, were isolated from dammar resin obtained from Shorea javanica K. & V. (Dipterocarpaceae). One of the acidic triterpenoids, dammarenolic acid (1), was converted to fourteen derivatives, namely, an alcohol, 21, an aldehyde, 22, and twelve L‐amino acid conjugates, 23–34. Compounds 1–34 were examined for their inhibitory effects on the induction of Epstein–Barr virus early antigen (EBV‐EA) by 12‐O‐tetradecanoylphorbol 13‐acetate (TPA) in Raji cells, a known primary screening test for antitumor promoters. All of the compounds tested, except for compounds 4, 5, 12–14, 16, and 17, showed inhibitory effects against EBV‐EA activation with potencies either comparable with or stronger than that of β‐carotene, a known natural antitumor promoter. In addition, (20S)‐20‐hydroxy‐3,4‐secodammara‐4(28),24‐dien‐3‐al (22) exhibited inhibitory effects on skin tumor promotion in an in vivo two‐stage mouse skin carcinogenesis test based on 7,12‐dimethylbenz[a]anthracene (DMBA) as initiator, and with TPA as promoter. Furthermore, evaluation of the cytotoxic activities of compounds 1–34 against human cancer cell lines showed that reduction (i.e., 21 and 22) or conjugation with L‐amino acids (i.e., 23–34) of compound 1 enhanced the cytotoxicity against human melanoma cell line CRL1579.
- 1 January 2000
- Published by Pharmaceutical Society of Japan in Chemical and Pharmaceutical Bulletin
- Vol. 48 (8) , 1187-1189
6S,8R-Stereochemistry of the C27- and C29-Alkane-6,8-diols Isolated from Three Compositae Flowers.
The Deltadelta (deltaS-deltaR) values for the C-1 methyl 1H signals in the 1H-NMR spectroscopy of the bis-MTPA esters of four synthetic stereoisomers of alkane-6,8-diols, viz., bis-MTPA esters of (6S,8R)-C27- (1a) and C29- (3a) (Deltadelta = -0.05 ppm), (6R,8S)-C27- (2a) and C29- (4a) (Deltadelta = +0.05 ppm), (6S,8S)-C27- (5a) (Deltadelta = -0.01 ppm), and (6R,8R)-C27- (6a) (Deltadelta = +0.01 ppm) alkane-6,8-diols, made it possible to differentiate unequivocally among the four stereoisomers. This allowed the determination of the (6S,8R)-stereochemistry (Deltadelta = -0.05 ppm for the bis-MTPA esters) for the natural C27- and C29-alkane-6,8-diols isolated from the flowers of three Compositae plants, Carthamus tinctorius, Cynara cardanclus, and Taraxacum platycarpum.
- 1 January 2000
- Published by Pharmaceutical Society of Japan in Chemical and Pharmaceutical Bulletin
- Vol. 48 (8) , 1187-1189
6S,8R-Stereochemistry of the C27- and C29-Alkane-6,8-diols Isolated from Three Compositae Flowers.
The Deltadelta (deltaS-deltaR) values for the C-1 methyl 1H signals in the 1H-NMR spectroscopy of the bis-MTPA esters of four synthetic stereoisomers of alkane-6,8-diols, viz., bis-MTPA esters of (6S,8R)-C27- (1a) and C29- (3a) (Deltadelta = -0.05 ppm), (6R,8S)-C27- (2a) and C29- (4a) (Deltadelta = +0.05 ppm), (6S,8S)-C27- (5a) (Deltadelta = -0.01 ppm), and (6R,8R)-C27- (6a) (Deltadelta = +0.01 ppm) alkane-6,8-diols, made it possible to differentiate unequivocally among the four stereoisomers. This allowed the determination of the (6S,8R)-stereochemistry (Deltadelta = -0.05 ppm for the bis-MTPA esters) for the natural C27- and C29-alkane-6,8-diols isolated from the flowers of three Compositae plants, Carthamus tinctorius, Cynara cardanclus, and Taraxacum platycarpum.